Rafferty Asset Management, LLC Bionano Genomics, Inc. Transaction History

Rafferty Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$1.4 - $25.4 $19,931 - $361,619	-14,237 Reduced 24.46%	43,973 $64,000
Q3 2022 Nov 14, 2022	SELL	$0.36 - $36.0 $948 - $94,824	-2,634 Reduced 4.33%	58,210 $107,000
Q2 2022 Aug 12, 2022	BUY	$12.3 - $27.3 $493,082 - $1.09 Million	40,088 Added 193.14%	60,844 $84,000
Q1 2022 May 13, 2022	BUY	$16.6 - $32.3 $119,188 - $231,913	7,180 Added 52.89%	20,756 $54,000
Q4 2021 Feb 10, 2022	BUY	$29.9 - $61.2 $405,922 - $830,851	13,576 New	13,576 $41,000

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $58M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.